Arcturus Therapeutics Holdings Inc. (ARCT)
NASDAQ·Healthcare·Biotechnology
$8.89
+7.11%
Mkt Cap $235.91M
EPS — Estimate vs Actual
Revenue — Estimate vs Actual
Quarterly History
| Q1 2026 Mar 3, 2026 | $15.90M | $7.20M | -54.75% | -$0.92 | -$1.03 | -11.96% | — | — |
| Q4 2025 Nov 10, 2025 | $16.03M | $17.15M | +6.97% | -$0.80 | -$0.49 | +38.71% | — | — |
| Q3 2025 Aug 11, 2025 | $18.34M | $24.51M | +33.62% | -$1.11 | -$0.34 | +69.37% | — | — |
| Q2 2025 May 12, 2025 | $23.35M | $29.38M | +25.84% | -$1.58 | -$0.52 | +67.09% | — | — |
| Q1 2025 Mar 6, 2025 | $44.64M | $21.00M | -52.96% | -$0.33 | -$1.11 | -236.36% | — | — |
| Q4 2024 Nov 7, 2024 | $45.92M | $38.81M | -15.48% | -$0.70 | -$0.26 | +62.86% | — | — |
| Q3 2024 Aug 5, 2024 | $34.25M | $45.98M | +34.24% | -$1.85 | -$0.64 | +65.41% | — | — |
| Q2 2024 May 8, 2024 | $17.54M | $32.60M | +85.85% | -$1.17 | -$1.00 | +14.53% | — | — |
| Q1 2024 Mar 7, 2024 | $37.86M | $28.21M | -25.48% | -$1.69 | -$0.32 | +81.07% | — | — |
| Q4 2023 Nov 14, 2023 | $41.64M | $43.38M | +4.17% | -$1.79 | -$0.61 | +65.92% | — | — |
| Q3 2023 Aug 7, 2023 | $48.50M | $9.56M | -80.28% | $0.09 | -$1.98 | -2300.00% | — | — |
| Q2 2023 May 9, 2023 | $37.94M | $79.73M | +110.14% | $2.92 | $0.88 | -69.86% | — | — |
| Q1 2023 Mar 28, 2023 | $72.68M | $160.05M | +120.21% | $0.98 | $4.43 | +352.04% | — | — |
| Q4 2022 Nov 9, 2022 | $4.57M | $13.37M | +192.86% | -$2.01 | -$1.33 | +33.83% | — | — |
| Q3 2022 Aug 9, 2022 | $3.14M | $27.09M | +763.69% | -$1.84 | -$0.82 | +55.43% | — | — |
| Q2 2022 May 9, 2022 | $7.08M | $5.24M | -25.96% | -$1.29 | -$1.94 | -50.39% | — | — |
| Q1 2022 Feb 28, 2022 | $14.75M | $5.79M | -60.72% | -$1.77 | -$1.47 | +16.95% | — | — |
| Q4 2021 Nov 8, 2021 | $11.65M | $2.44M | -79.08% | -$1.40 | -$2.05 | -46.43% | — | — |
| Q3 2021 Aug 9, 2021 | $2.00M | $2.00M | +0.00% | -$1.99 | -$2.07 | -4.02% | — | — |
| Q2 2021 May 10, 2021 | $1.47M | $2.13M | +44.30% | -$1.16 | -$2.15 | -85.34% | — | — |